To keep a finger on the pulse of innovative orthopedic technologies close to entering or on the market, we highlight Canary Medical, Carlsmed, Garwood Medical Devices and numerous other companies that have participated in FDA's Breakthrough Devices Program.
Based on his experience in the spine space, Uri Armin believes that new and innovative ideas for orthopedic implants require a balance between evolution and revolution.
To be a prolific problem-solver, you need to ensure that you are asking the right questions. The March issue of BONEZONE captures actions and advice from some of the industry's great problem solvers.
We pull advice from the archives as a reminder that all elements of commercialization should work together, and that your value inside your organization is proportional to your contribution to its directives.
Using a thorough supplier risk assessment during DFM is critical in creating a robust supply chain that can prevail in both ideal and non-ideal conditions.
By recording actual results, instead of pass/fail, you can better investigate failures that may occur in production/post-production. This approach also helps to verify the specification you originally developed is appropriate and effective for your products.
You’ll discover how R&D leaders overcame difficult situations due to COVID-19 and how product development processes may change forever as a result. Register
As the hospital environment becomes more complex, traditional approaches to establishing relationships, selling products and servicing accounts have become less effective for orthopedic manufacturers.
